RARE Alert: Reckitt Benckiser said to be working with Robey Warshaw on major deal - part 2

It's good to see little old Betaville's RARE story about Reckitt Benckiser followed up in the British stock market reports this morning.

Just over a month ago I wrote that Reckitt was working with (which is different to formally appointing) uber bankers at Robey Warshaw on a major deal. Here is a link to that piece:

Tuesday review - part 2

I should have mentioned this piece from the Financial Times - http://www.ft.com/cms/s/0/3a26241c-81b0-11e5-8095-ed1a37d1e096.html#axzz3qQcDFYoP - in my earlier post.

It's bit of "old" news (the fact that Pfizer approached GlaxoSmithKline before Allergan) that hadn't made into the public domain. But as it has been shown here on little old Betaville, "old" news can often become "new" news, so in the right circumstances is definitely worth reporting. Hat tip, then, to the raft of FT hacks who discovered the "old" news.

Big scoop from the WSJ - Pfizer in $300 billion merger talks with Allergan

Yes - you read the headline correctly.

When you wake up this morning, you might want to check out this cracking tale from the venerable Wall Street Journal:

A further update to my what's missing from AbbVie's £27 billion takeover bid for Shire story?

I wonder whether the market will finally find out whether Lazard has secured a role on the AbbVie/Shire deal?

(for readers wondering why I have posited this question it might be worthwhile clicking on the link to this previous article: http://betaville123.blogspot.co.uk/2014/06/whats-missing-from-abbvies-27-billion.html).